|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Perivascular Fat and the Mi-crocirculation: Relevance to Insulin Resistance, Diabetes, and Cardio-vascular Disease显示文摘 | Houben AJ Eringa EC Jonk AM | 2012 | Curr Cardiovasc Risk Rep2012，6，1： | 1 |
| 2 | Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium显示文摘 | Eringa EC Stehouwer CD van Nieuw Amerongen GP | 2004 | Am J Physiol Heart Circ Physiol2004，287，5： | 1 |
| 3 | PerivascuIar Fat and the Microcirculation: relevance to insulin resistance, diabetes, andcardiovascular disease显示文摘 | Houben AJ Eringa EC Jonk AM | 2012 | Curr Cardiovasc Risk Rep2012，6，1： | 1 |
| 4 | Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity 显示文摘 | Bakker W Eringa EC Sipkema P | 2009 | Cell Tissue Res2009，335，1： | 1 |
| 5 | Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles显示文摘 | Stehouwer CD Merlijin T | 2002 | Cardiovasc Res2002，56，3： | 1 |
| 6 | Perivascular Fat and the Microcirculation:Relevance to Insulin Resistance, Diabetes,and Cardiovascular Disease显示文摘 | Houben AJ Eringa EC Jonk AM | 2012 | Curt Cardiovasc Risk Rep2012，6，1： | 1 |
| 7 | Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles显示文摘 | Eringa EC Stehouwer CD Merlijn T | 2002 | Cardiovasc Res2002，56，3： | 1 |
| 8 | 'Vasocrine' signalling from perivascular fat:a mechanism linking insulin resistance to vascular disease显示文摘 | Yudkin JS Eringa E Stehouwer CD | | 0，，9473： | 1 |
| 9 | Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or P13-kinase in skeletal muscle arterioles显示文摘 | Eringa EC Stehouwer CD Merlijn T | 2002 | Cardiovasc Res2002，56，3： | 1 |
| 10 | Vasocrine ' signalling from perivascular fat:a mechanism linking insulin resistance to vascular disease 显示文摘 | Yudkin JS Eringa E Stehouwer CD | 2005 | Lancet2005，365，9473： | 1 |
| 11 | Microvascular dys-function: a potential pathophysiological role in the metabolicsyndrome显示文摘 | Sernc EH dc Jongh RT Eringa EC | 2007 | Hypertension2007，50，1： | 1 |
| 12 | Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity显示文摘 | Bakker W Eringa EC Sipkema P | 2009 | Cell and Tissue Research2009，335，1： | 1 |
| 13 | Perivascular fat and the microcirculation: relevance to insulin resistance, diabetes, and cardiovascular disease显示文摘 | Houben A J Eringa EC Jonk AM | 2012 | Curr Cardiovasc Risk Rep2012，6，： | 1 |
| 14 | Endothelial dysfunetion and diabetes:roles of hyperglycemia,impaired insulin signaling and obesity显示文摘 | Bakker W Eringa EC Sipkema P | 2009 | Cell Tissue Res2009，335，： | 1 |
| 15 | ″Vasocrine″signalling from perivascular fat:a mechanism linking insulin resistance to vascular disease显示文摘 | Yudkin JS Eringa E Stehouwer CD | 2005 | Lancet2005，365，9473： | 1 |
| 16 | Cardioprotection Via Activation of Protein Kinase C-δ Depends on Modulation of the Reverse Mode of the Na+/Ca2+ Exchanger显示文摘 | R Arthur Bouwman Kanita Salic F Gieneke Padding Etto C. Eringa Brechje J. van Beek-Harmsen Toshio Matsuda Akemichi Baba René J.P. Musters Walter J. Paulus Jaap J. de Lange Christa Boer | 2006 | 2006 (1 su)2006，，1： | 1 |
| 17 | Endothelial dysfunction and diabetes:roles of hyperglycemia,impaired insulin signaling and obesity显示文摘 | Bakker W Eringa EC Sipkema P | 2009 | Cell Tissue Res2009，335，1： | 1 |
| 18 | Critical success factors in yield man- agement: a development and analysis 显示文摘 | Hansen C N Eringa K | 1998 | Progress in Tourism and Hospitality Research1998，4，3： | 1 |
| 19 | Microvascular dysfunction:a potential pathophysiological role in the metabolic syndrome显示文摘 | Serne EH de Jongh RT Eringa Ec | 2007 | Hypertension2007，50，1： | 1 |
| 20 | Endothelialdysfunction in(pre)diabetes : characteristics, causativemechanisms and pathogenic role in type 2 diabetes显示文摘 | Eringa E C Seme E H Meijer R I | 2013 | RevEndocr Metab Disord2013，14，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员